miércoles, 30 de octubre de 2019

Guardant enters race for liquid biopsy with colon cancer study

Guardant enters race for liquid biopsy with colon cancer study

Go West

STAT Plus: Blood test maker Guardant enters race for liquid biopsy with colon cancer study

By MATTHEW HERPER


ANNIE CAVANAGH/WELLCOME
Guardant Health, whose study will include 10,000 patients, is being closely watched in the race to develop liquid biopsies.

No hay comentarios: